Patents by Inventor Ruth Tal-Singer

Ruth Tal-Singer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220023409
    Abstract: The present invention relates to immunogenic compositions comprising an immunogenic polypeptide from Haemophilus influenzae or an immunogenic fragment thereof and/or an immunogenic polypeptide from Moraxella catarrhalis or an immunogenic fragment thereof, for use in the treatment or prevention of a recurrence of an acute exacerbation of chronic obstructive pulmonary disease (AECOPD) resulting from a bacterial infection in a subject.
    Type: Application
    Filed: October 12, 2021
    Publication date: January 27, 2022
    Applicants: GLAXOSMITHKLINE BIOLOGICALS SA, GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
    Inventors: Catherine COHET, Jeanne-Marie Josephine DEVASTER, David MAYHEW, Bruce MILLER, Ruth TAL-SINGER, Vincent WEYNANTS, Thomas WILKINSON
  • Patent number: 11167022
    Abstract: The present invention relates to immunogenic compositions comprising an immunogenic polypeptide from Haemophilus influenzae or an immunogenic fragment thereof and/or an immunogenic polypeptide from Moraxella catarrhalis or an immunogenic fragment thereof, for use in the treatment or prevention of a recurrence of an acute exacerbation of chronic obstructive pulmonary disease (AECOPD) resulting from a bacterial infection in a subject.
    Type: Grant
    Filed: March 29, 2018
    Date of Patent: November 9, 2021
    Assignees: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED, GLAXOSMITHKLINE BIOLOGICALS SA
    Inventors: Catherine Cohet, Jeanne-Marie Josephine Devaster, David Mayhew, Bruce Miller, Ruth Tal-Singer, Vincent Weynants, Thomas Wilkinson
  • Publication number: 20200046823
    Abstract: The present invention relates to immunogenic compositions comprising an immunogenic polypeptide from Haemophilus influenzae or an immunogenic fragment thereof and/or an immunogenic polypeptide from Moraxella catarrhalis or an immunogenic fragment thereof, for use in the treatment or prevention of a recurrence of an acute exacerbation of chronic obstructive pulmonary disease (AECOPD) resulting from a bacterial infection in a subject.
    Type: Application
    Filed: March 29, 2018
    Publication date: February 13, 2020
    Inventors: Catherine COHET, Jeanne-Marie Josephine DEVASTER, David MAYHEW, Bruce MILLER, Ruth TAL-SINGER, Vincent WEYNANTS, Thomas WILKINSON
  • Publication number: 20050197307
    Abstract: This invention relates to host cellular factors as therapeutic and diagnostic compounds, and methods using such factors for screening for antiviral compounds, particularly compounds useful to treat Herpes virus infections, such as HSV-1 and HSV-2 infections.
    Type: Application
    Filed: December 17, 2004
    Publication date: September 8, 2005
    Inventors: Shelly Berger, Nigel Fraser, Jeffrey Leary, Ruth Tal-Singer
  • Publication number: 20040038854
    Abstract: The present invention is directed to the novel use of an IL-8 receptor antagonist for the treatment of human virus infections and the exacerbation of symptoms associated therewith.
    Type: Application
    Filed: January 15, 2003
    Publication date: February 26, 2004
    Inventors: Susan B. Dillon, Ruth Tal-Singer
  • Publication number: 20040022762
    Abstract: The present invention is directed to the novel use of an IL-8 protein modulator for the treatment of human virus infections and associated symptom exacerbations.
    Type: Application
    Filed: March 19, 2003
    Publication date: February 5, 2004
    Inventors: Susan B Dillon, Ruth Tal-Singer
  • Publication number: 20030175784
    Abstract: A genetic analysis method termed “fine array transcript mapping” or “FAT Mapping” is disclosed, which method is useful for detecting and measuring RNA molecules, which have been transcribed from a genome. The method can be applied to explore differential expression of a template genome, and for accurately mapping the 5′ ends of transcripts, which have been expressed. Further, the presence or absence in any particular biological circumstances of a given transcript and its relative concentration can define gene functions or coding capacities. Thus the method relates to mapping and identifying novel and known gene products and investigating gene functions and regulation.
    Type: Application
    Filed: March 13, 2003
    Publication date: September 18, 2003
    Applicant: SmithKline Beecham Corporation
    Inventors: Jeffrey J. Leary, Ruth Tal-Singer
  • Publication number: 20030113292
    Abstract: The present invention relates generally to the use of compositions comprising IL-18, also known as interferon-&ggr;-inducing factor (IGIF), and IL-18 in combination with other agents, for the prevention and/or treatment of viral diseases caused by HIV, HSV, HPV, HAV, HBV, and HCV.
    Type: Application
    Filed: December 2, 2002
    Publication date: June 19, 2003
    Inventors: Klaus M Esser, Martin Rosenberg, Ruth Tal-Singer, Gary Woodnutt, Francis V Chisari, Susan B Dillon